Hemo Organic Limited Announces Independent Director Resignation Under Regulation 30
Hemo Organic Limited has formally notified BSE Limited about the resignation of Independent Director Mr. Deepak Ashokkumar Rochani (DIN: 11041560), effective from March 31, 2026. The resignation was attributed to pre-occupation and other professional commitments, with comprehensive regulatory documentation provided under SEBI Regulation 30.

*this image is generated using AI for illustrative purposes only.
Hemo Organic Limited has formally announced the resignation of Independent Director Mr. Deepak Ashokkumar Rochani, effective from the closure of business hours on March 31, 2026. The company submitted the required intimation to BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Director Resignation Details
Mr. Deepak Ashokkumar Rochani (DIN: 11041560) submitted his resignation from the position of Independent Director due to pre-occupation and other professional commitments. The resignation was processed on March 31, 2026, with Managing Director Vishwambar Kameshwar Singh (DIN: 09822587) signing the official communication to BSE Limited.
| Parameter: | Details |
|---|---|
| Director Name: | Mr. Deepak Ashokkumar Rochani |
| DIN: | 11041560 |
| Position: | Independent Director |
| Effective Date: | March 31, 2026 |
| Reason: | Pre-occupation and professional commitments |
| Board Committees: | 3 |
In his resignation letter, Mr. Rochani confirmed that there are no other material reasons for his departure beyond those mentioned. He expressed gratitude to the Board of Directors and colleagues for their support during his tenure.
Regulatory Compliance and Documentation
The company provided comprehensive documentation as required under SEBI regulations, including the complete resignation letter and detailed annexure. The filing was made pursuant to Regulation 30 read with SEBI circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
| Compliance Aspect: | Details |
|---|---|
| Regulation: | SEBI Regulation 30 |
| Scrip Code: | 524590 |
| Scrip Symbol: | HEMORGANIC |
| ISIN: | INE422G01015 |
| Filing Date: | March 31, 2026 |
Committee Impact and Reconstitution
Following Mr. Rochani's resignation, he stepped down from all board committees where he served as Chairman or Member. The company had previously reconstituted all three board committees with effect from April 1, 2026, ensuring continuity in governance structure.
Current Committee Structure
| Committee: | Chairman | Members |
|---|---|---|
| Audit Committee: | Ms. Rina Kumari | Ms. Hiral Vinodbhai Patel, Mr. Vishwambar Kameshwar Singh |
| Nomination and Remuneration: | Ms. Rina Kumari | Ms. Hiral Vinodbhai Patel, Mr. Vishwambar Kameshwar Singh |
| Stakeholders Grievance: | Ms. Rina Kumari | Ms. Hiral Vinodbhai Patel, Mr. Vishwambar Kameshwar Singh |
The reconstituted committees maintain consistent membership across all three committees, with Ms. Rina Kumari serving as Chairman and the same composition of members ensuring streamlined governance operations.
Historical Stock Returns for Hemo Organic
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.00% | -9.24% | -30.32% | +9.62% | +26.39% | -23.95% |
Will Hemo Organic recruit a new independent director to maintain board diversity and independence ratios?
How might the concentration of committee leadership under Ms. Rina Kumari affect governance oversight and decision-making processes?
Could this resignation signal broader governance challenges or strategic shifts within Hemo Organic's management structure?



























